Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

Verstovsek, Srdan ; Mesa, Ruben A ; Gotlib, Jason ; Gupta, Vikas ; DiPersio, John F ; Catalano, John V ; Deininger, Michael W N ; Miller, Carole B ; Silver, Richard T ; Talpaz, Moshe ; Winton, Elliott F ; Harvey, Jr, Jimmie H ; Arcasoy, Murat O ; Hexner, Elizabeth O ; Lyons, Roger M ; Paquette, Ronald ; Raza, Azra ; Jones, Mark ; Kornacki, Deanna ; Sun, Kang ; Kantarjian, Hagop

Journal of hematology and oncology, 2017-02, Vol.10 (1), p.55-14, Article 55 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível